Last Updated on December 31, 2023 by The Health Master
Ahmedabad: Alembic Pharmaceuticals Ltd on Friday said the US health regulator has issued a Form-483 with two minor procedural observations following inspection of its injectable and ophthalmic facility (F-3) located at Karkhadi in Gujarat.
The US Food and Drug Administration (USFDA) had inspected the plant from March 16-24, 2023, the company said in a regulatory filing.
As per US Food and Drug Administration (USFDA), Form 483 is issued to a firm’s management at the conclusion of an inspection when the investigator has observed any conditions that may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.
“None of the observations are related to data integrity and management believes that they are addressable,” it said.
The company is preparing the response to the observations, which will be submitted to the USFDA within the stipulated period, Alembic added.
In a separate filing, the company said the Brazilian Health Regulatory Agency (ANVISA) has completed a good manufacturing practice audit at API-III facility at Karakhadi without any observations for its 56 active pharmaceutical ingredients.
The inspection was conducted from March 20-24, 2023, it added.
USFDA issues Form 483 with 3 observations to Bliss GVS Pharma, Maharashtra
USFDA issues Form 483 with one observation to Torrent, Gujarat
USFDA issues Form 483 with 4 observations to Indoco Remedies, Goa
USFDA issues Form 483 with 8 observations to Cipla for Pithampur facility
USFDA issues Form 483 with 2 observations to Laurus Labs for Visakhapatnam facility
USFDA issues 2 observations to Natco Pharma for Vizag facility
USFDA gives approval for Calcipotriene and Betamethasone foam
West Bengal notice to Pharma Industry on bio-resource use
USFDA gives approval for Brexpiprazole tablets
Govt constitutes panel for PLI scheme for pharmaceuticals
USFDA gives approval for generic Rocuronium Bromide Injection
Difference: Disintegration and Dissolution test in pharma industry
USFDA gives approval for Prochlorperazine Maleate Tablets USP
How to prepare SOPs in the Pharma Industry
Difference between branded and generic medicines
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
